110 related articles for article (PubMed ID: 8854841)
1. In vivo imaging of chromogranin A-positive endocrine tumours by three-step monoclonal antibody targeting.
Siccardi AG; Paganelli G; Pontiroli AE; Pelagi M; Magnani P; Viale G; Faglia G; Fazio F
Eur J Nucl Med; 1996 Nov; 23(11):1455-9. PubMed ID: 8854841
[TBL] [Abstract][Full Text] [Related]
2. Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
Magnani P; Paganelli G; Songini C; Samuel A; Sudati F; Siccardi AG; Fazio F
Br J Cancer; 1996 Sep; 74(5):825-31. PubMed ID: 8795589
[TBL] [Abstract][Full Text] [Related]
3. Three-step immunoscintigraphy with anti-chromogranin A monoclonal antibody in tumours of the pituitary region.
Colombo P; Siccardi AG; Paganelli G; Magnani P; Songini C; Buffa R; Faglia G; Fazio F
Eur J Endocrinol; 1996 Aug; 135(2):216-21. PubMed ID: 8810736
[TBL] [Abstract][Full Text] [Related]
4. Combined use of 111In-labeled pentetreotide and three-step immunoscintigraphy with antichromogranin A monoclonal antibody in the diagnosis of pituitary adenomas.
Magnani P; Paganelli G; Siccardi AG; Songini C; Colombo P; Faglia G; Fazio F
Cell Biophys; 1994; 24-25():307-13. PubMed ID: 7736536
[TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy with anti-chromogranin A antibodies in patients with endocrine/neuroendocrine tumors.
Colombo P; Paganelli G; Magnani P; Songini C; Fazio F; Faglia G
J Endocrinol Invest; 1993 Nov; 16(10):841-3. PubMed ID: 8144860
[No Abstract] [Full Text] [Related]
6. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies.
Portel-Gomes GM; Grimelius L; Johansson H; Wilander E; Stridsberg M
Am J Surg Pathol; 2001 Oct; 25(10):1261-7. PubMed ID: 11688460
[TBL] [Abstract][Full Text] [Related]
8. Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas.
Rosa P; Bassetti M; Weiss U; Huttner WB
J Histochem Cytochem; 1992 Apr; 40(4):523-33. PubMed ID: 1552186
[TBL] [Abstract][Full Text] [Related]
9. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
[TBL] [Abstract][Full Text] [Related]
10. Imaging of bronchial carcinoid tumors associated to Cushing syndrome with 111In-Octreoscan scintigraphy and immunoscintigraphy with anti-chromogranin monoclonal antibodies. Report of two cases.
Carretta A; Chiesa G; Magnani P; Songini C; Melloni G; Zannini P; Grossi A
J Cardiovasc Surg (Torino); 1997 Apr; 38(2):191-4. PubMed ID: 9201136
[TBL] [Abstract][Full Text] [Related]
11. A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Endocrinol (Copenh); 1990 Feb; 122(2):145-55. PubMed ID: 2316306
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19.
Deftos LJ; Woloszczuk W; Krisch I; Horvat G; Ulrich W; Neuhold N; Braun O; Reiner A; Srikanta S; Krisch K
Am J Med; 1988 Dec; 85(6):780-4. PubMed ID: 3195602
[TBL] [Abstract][Full Text] [Related]
13. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A, B, and C in human adrenal medulla and endocrine tissues.
Hagn C; Schmid KW; Fischer-Colbrie R; Winkler H
Lab Invest; 1986 Oct; 55(4):405-11. PubMed ID: 3762065
[TBL] [Abstract][Full Text] [Related]
15. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors.
Lloyd RV; Cano M; Rosa P; Hille A; Huttner WB
Am J Pathol; 1988 Feb; 130(2):296-304. PubMed ID: 3341449
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
[TBL] [Abstract][Full Text] [Related]
17. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody.
Wilson BS; Lloyd RV
Am J Pathol; 1984 Jun; 115(3):458-68. PubMed ID: 6375394
[TBL] [Abstract][Full Text] [Related]
18. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
19. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new chromogranin B fragment (314-365) in endocrine tumors.
Woussen-Colle MC; Gourlet P; Vandermeers A; Vandermeers-Piret MC; D'Haens J; Velkeniers B; Robberecht P
Peptides; 1995; 16(2):231-6. PubMed ID: 7784254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]